Price Chart

Profile

Sinovac Biotech Ltd is a biopharmaceutical company. The company focuses on the research, development, manufacturing, and commercialization of vaccines for infectious diseases. Its product portfolio includes vaccines against hepatitis A and B, seasonal influenza, H5N1 pandemic influenza (avian flu), H1N1 influenza (swine flu), mumps, and canine rabies. The company also provides services for disease control and prevention, collaborating with the Chinese governments at the national, state, and local levels. It sells its vaccines in China, while also exploring growth opportunities in international markets.
URL http://www.sinovac.com
Investor Relations URL http://www.sinovac.com/en-us/Investors
HQ State/Province N/A
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Growth
Next Earnings Release Feb. 27, 2024 (est.)
Last Earnings Release Feb. 27, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Sinovac Biotech Ltd is a biopharmaceutical company. The company focuses on the research, development, manufacturing, and commercialization of vaccines for infectious diseases. Its product portfolio includes vaccines against hepatitis A and B, seasonal influenza, H5N1 pandemic influenza (avian flu), H1N1 influenza (swine flu), mumps, and canine rabies. The company also provides services for disease control and prevention, collaborating with the Chinese governments at the national, state, and local levels. It sells its vaccines in China, while also exploring growth opportunities in international markets.
URL http://www.sinovac.com
Investor Relations URL http://www.sinovac.com/en-us/Investors
HQ State/Province N/A
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Growth
Next Earnings Release Feb. 27, 2024 (est.)
Last Earnings Release Feb. 27, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A